EP1569675A4 - Nouvelles sequences de galectine, et compositions et methodes utilisant celles-ci pour traiter ou diagnostiquer l'arthrite et d'autres maladies inflammatoires chroniques - Google Patents

Nouvelles sequences de galectine, et compositions et methodes utilisant celles-ci pour traiter ou diagnostiquer l'arthrite et d'autres maladies inflammatoires chroniques

Info

Publication number
EP1569675A4
EP1569675A4 EP03772618A EP03772618A EP1569675A4 EP 1569675 A4 EP1569675 A4 EP 1569675A4 EP 03772618 A EP03772618 A EP 03772618A EP 03772618 A EP03772618 A EP 03772618A EP 1569675 A4 EP1569675 A4 EP 1569675A4
Authority
EP
European Patent Office
Prior art keywords
sequences
compositions
treating
inflammatory diseases
chronic inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03772618A
Other languages
German (de)
English (en)
Other versions
EP1569675A2 (fr
Inventor
Itshak Golan
Lora Melnik
Dan Caspi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yissum Research Development Co of Hebrew University of Jerusalem
Original Assignee
Yissum Research Development Co of Hebrew University of Jerusalem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Research Development Co of Hebrew University of Jerusalem filed Critical Yissum Research Development Co of Hebrew University of Jerusalem
Publication of EP1569675A2 publication Critical patent/EP1569675A2/fr
Publication of EP1569675A4 publication Critical patent/EP1569675A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726—Lectins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP03772618A 2002-11-14 2003-11-13 Nouvelles sequences de galectine, et compositions et methodes utilisant celles-ci pour traiter ou diagnostiquer l'arthrite et d'autres maladies inflammatoires chroniques Withdrawn EP1569675A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US42604102P 2002-11-14 2002-11-14
US426041P 2002-11-14
US42869102P 2002-11-25 2002-11-25
US428691P 2002-11-25
PCT/IL2003/000960 WO2004043332A2 (fr) 2002-11-14 2003-11-13 Nouvelles sequences de galectine, et compositions et methodes utilisant celles-ci pour traiter ou diagnostiquer l'arthrite et d'autres maladies inflammatoires chroniques

Publications (2)

Publication Number Publication Date
EP1569675A2 EP1569675A2 (fr) 2005-09-07
EP1569675A4 true EP1569675A4 (fr) 2009-08-12

Family

ID=32314619

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03772618A Withdrawn EP1569675A4 (fr) 2002-11-14 2003-11-13 Nouvelles sequences de galectine, et compositions et methodes utilisant celles-ci pour traiter ou diagnostiquer l'arthrite et d'autres maladies inflammatoires chroniques

Country Status (4)

Country Link
EP (1) EP1569675A4 (fr)
AU (1) AU2003279511A1 (fr)
CA (1) CA2505931A1 (fr)
WO (1) WO2004043332A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060009378A1 (en) * 2002-11-14 2006-01-12 Itshak Golan Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
JPWO2005121340A1 (ja) * 2004-06-14 2008-04-10 株式会社ガルファーマ 新規ガレクチン８改変体タンパク質及びその用途
JP2007126388A (ja) * 2005-11-02 2007-05-24 Galpharma Co Ltd マスト細胞安定化剤

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998015624A1 (fr) * 1996-10-09 1998-04-16 Human Genome Sciences, Inc. Galectine 8, 9, 10, et 10sv
US5869289A (en) * 1996-10-09 1999-02-09 Incyte Pharmaceuticals, Inc. Human galectin homolog
WO1999012041A1 (fr) * 1997-09-05 1999-03-11 The Board Of Regents Of The University Of Oklahoma Composition et methodes utilisant la galectine-1
JP2003246749A (ja) * 2002-02-22 2003-09-02 Galpharma Co Ltd 好中球接着誘導剤
WO2003072606A2 (fr) * 2002-02-28 2003-09-04 Yeda Research And Development Company Ltd. Agents de liaison de glycoproteines cd44 et methodes d'utilisation associees

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5908761A (en) * 1993-12-05 1999-06-01 Yeda Research And Development Co. Ltd. Galectin-8 and galectin-8-like proteins and DNA molecules coding therefor
US6027916A (en) * 1996-10-09 2000-02-22 Human Genome Sciences, Inc. Galectin 9 and 10SV Polynucleotides

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998015624A1 (fr) * 1996-10-09 1998-04-16 Human Genome Sciences, Inc. Galectine 8, 9, 10, et 10sv
US5869289A (en) * 1996-10-09 1999-02-09 Incyte Pharmaceuticals, Inc. Human galectin homolog
WO1999012041A1 (fr) * 1997-09-05 1999-03-11 The Board Of Regents Of The University Of Oklahoma Composition et methodes utilisant la galectine-1
JP2003246749A (ja) * 2002-02-22 2003-09-02 Galpharma Co Ltd 好中球接着誘導剤
WO2003072606A2 (fr) * 2002-02-28 2003-09-04 Yeda Research And Development Company Ltd. Agents de liaison de glycoproteines cd44 et methodes d'utilisation associees

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BIDON NATHALIE ET AL: "Galectin-8: A complex sub-family of galectins (Review)", INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, vol. 8, no. 3, September 2001 (2001-09-01), pages 245 - 250, XP008107660, ISSN: 1107-3756 *
LAHM HARALD ET AL: "Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures", JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, vol. 127, no. 6, 2001, pages 375 - 386, XP002534530, ISSN: 0171-5216 *
LEVY Y ET AL: "Galectin-8 functions as a matricellular modulator of cell adhesion.", THE JOURNAL OF BIOLOGICAL CHEMISTRY 17 AUG 2001, vol. 276, no. 33, 17 August 2001 (2001-08-17), pages 31285 - 31295, XP002534531, ISSN: 0021-9258 *

Also Published As

Publication number Publication date
AU2003279511A1 (en) 2004-06-03
WO2004043332A2 (fr) 2004-05-27
WO2004043332A3 (fr) 2005-02-10
CA2505931A1 (fr) 2004-05-27
AU2003279511A8 (en) 2004-06-03
EP1569675A2 (fr) 2005-09-07

Similar Documents

Publication Publication Date Title
AU2003231132A8 (en) Methods and compositions for diagnosing and monitoring auto immune and chronic inflammatory diseases
EP1667730A4 (fr) Compositions et procedes pour le traitement de la maladie pulmonaire inflammatoire
DE60223721D1 (en) Docking-informationssystem für schiffe
IL208191A0 (en) Compositions and methods for treating rage-associated disorders
ZA200500741B (en) Compositions against inflammatory processes
NO20052193D0 (no) Korrosjonshemmende sammensetning
IL175610A0 (en) Methods and reagents for the treatment of inflammatory disorders
GB2392738B (en) Screw compressor
EP1450820A4 (fr) Methode de traitement et de prevention de maladies inflammatoires
EP1636251A4 (fr) Compositions de ccn1 et methodes associees
AU2003279511A8 (en) Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
EP1572085A4 (fr) Methodes et compositions pour traiter et diagnostiquer le diabete
AU2003237150A1 (en) Compositions and methods for treating inflammatory connective tissue diseases
AU2003301348A8 (en) Compositions and methods for diagnosing and treating autoimmune disease
AU2003294291A8 (en) Descaling and corrosion inhibiting composition
ZA200610474B (en) Compositions and methods for treating inflammatory disorders
AU2003291730A8 (en) Methods and compositions for treating neurodegenerative diseases
IL187244A0 (en) Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
EP1608316A4 (fr) Methode et compositions pour le traitement et la prevention d'etats inflammatoires
AU2003252187A8 (en) Topical composition for the treatment of inflammatory conditions of the skin
IL163878A0 (en) Compositions and methods for treating mdma-inducedtoxicity
AU2003906810A0 (en) Methods and compositions for treating inflammatory conditions
EP1667677A4 (fr) Composition de traitement de la maladie intestinale inflammatoire
IL218580A0 (en) Compositions and methods for diagnosing and treating an inflammation
AU2002322349A8 (en) Methods and compositions for the diagnosis and treatment of demyelinating inflammatory disorders

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050531

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK

AX Request for extension of the european patent

Extension state: AL LT LV MK

RAX Requested extension states of the european patent have changed

Extension state: LT

Payment date: 20050531

RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/68 20060101ALI20090701BHEP

Ipc: C07K 16/28 20060101ALI20090701BHEP

Ipc: C12N 15/74 20060101ALI20090701BHEP

Ipc: C12N 1/20 20060101ALI20090701BHEP

Ipc: C12P 21/06 20060101ALI20090701BHEP

Ipc: C07K 14/47 20060101ALI20090701BHEP

Ipc: A61K 38/00 20060101AFI20050715BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20090710

17Q First examination report despatched

Effective date: 20091209

RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/68 20060101ALI20120514BHEP

Ipc: C07K 16/28 20060101ALI20120514BHEP

Ipc: A61K 38/17 20060101ALI20120514BHEP

Ipc: A61K 39/395 20060101ALI20120514BHEP

Ipc: C07K 14/47 20060101AFI20120514BHEP

Ipc: G01N 33/53 20060101ALI20120514BHEP

Ipc: C12P 21/02 20060101ALI20120514BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RBV Designated contracting states (corrected)

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20121106